Intracellular defenses against HIV, viral evasion and novel therapeutic approaches
- PMID: 21741003
- DOI: 10.1016/S0929-6646(11)60053-3
Intracellular defenses against HIV, viral evasion and novel therapeutic approaches
Abstract
Human immunodeficiency virus (HIV), the causative agent of AIDS, is a retrovirus. It is estimated that, while in the cell, it interacts with almost 10% of cellular proteins. Several of these have evolved to protect the cell from infection with retroviruses and are known as "restriction factors". Restriction factors tell us much about how the virus functions and open up new paradigms for exploring novel antiviral therapeutics. This article gives an update on the three best studied restriction factors, their putative mechanisms of action and how the virus has overcome their effects, together with an indication of novel therapeutic approaches based on this knowledge.
Copyright © 2011 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.
Similar articles
-
HIV Restriction Factors and Mechanisms of Evasion.Cold Spring Harb Perspect Med. 2012 May;2(5):a006940. doi: 10.1101/cshperspect.a006940. Cold Spring Harb Perspect Med. 2012. PMID: 22553496 Free PMC article. Review.
-
Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5166-71. doi: 10.1073/pnas.0913650107. Epub 2010 Mar 1. Proc Natl Acad Sci U S A. 2010. PMID: 20194752 Free PMC article.
-
Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.Trends Microbiol. 2008 Dec;16(12):612-9. doi: 10.1016/j.tim.2008.08.013. Epub 2008 Oct 29. Trends Microbiol. 2008. PMID: 18976920 Free PMC article. Review.
-
Human immunodeficiency virus, restriction factors, and interferon.J Interferon Cytokine Res. 2009 Sep;29(9):569-80. doi: 10.1089/jir.2009.0077. J Interferon Cytokine Res. 2009. PMID: 19694548 Free PMC article. Review.
-
Human cellular restriction factors that target HIV-1 replication.BMC Med. 2009 Sep 16;7:48. doi: 10.1186/1741-7015-7-48. BMC Med. 2009. PMID: 19758442 Free PMC article. Review.
Cited by
-
The emergence of drug resistant HIV variants and novel anti-retroviral therapy.Asian Pac J Trop Biomed. 2013 Jul;3(7):515-22. doi: 10.1016/S2221-1691(13)60106-9. Asian Pac J Trop Biomed. 2013. PMID: 23835806 Free PMC article. Review.
-
Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells.Mol Cells. 2012 Apr;33(4):335-41. doi: 10.1007/s10059-012-2287-0. Epub 2012 Mar 23. Mol Cells. 2012. PMID: 22450687 Free PMC article.
-
Innate immune evasion strategies by human immunodeficiency virus type 1.ISRN AIDS. 2013 Aug 12;2013:954806. doi: 10.1155/2013/954806. ISRN AIDS. 2013. PMID: 24052891 Free PMC article. Review.
-
SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.J Immunol Res. 2017;2017:1548905. doi: 10.1155/2017/1548905. Epub 2017 Nov 22. J Immunol Res. 2017. PMID: 29359168 Free PMC article. Review.
-
Large Isoform of Mammalian Relative of DnaJ is a Major Determinant of Human Susceptibility to HIV-1 Infection.EBioMedicine. 2014 Oct 7;1(2-3):126-32. doi: 10.1016/j.ebiom.2014.10.002. eCollection 2014 Dec. EBioMedicine. 2014. PMID: 26137520 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
